HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vaughan, R. A. Articles by Kuhar, M. J. Search for Related Content PubMed PubMed Citation Articles by Vaughan, R. A. Articles by Kuhar, M. J. Social Bookmarking                      What's this?

Volume 271, Number 35, Issue of August 30, 1996 pp. 21672-21680
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Dopamine Transporter Ligand Binding Domains
STRUCTURAL AND FUNCTIONAL PROPERTIES REVEALED BY LIMITED PROTEOLYSIS

(Received for publication, April 24, 1996, and in revised form, June 20, 1996)

Roxanne A. Vaughan and Michael J. Kuhar ^¶

From the  Neuroscience Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland 21224 and ^¶ Neuroscience Division, Yerkes Regional Primate Center, Emory University, Atlanta, Georgia 30322

Dopamine transporters (DATs) are members of the Na⁺- and Cl-dependent neurotransmitter and amino acid transporter family predicted by hydrophobicity analysis to have 12 transmembrane-spanning helices. The structure of DAT was studied using the photoaffinity compounds [¹²⁵I]1-[2-(diphenylmethoxy)-ethyl]-4-[2-(4-azido-3-iodophenyl)ethyl]piperazine ([¹²⁵I]DEEP), a 1-(2-diphenylmethoxy)-ethyl-4-(3-phenyl propyl)piperazine (GBR analog), and [¹²⁵I]-3-(p-chlorophenyl)tropane-2-carboxylic acid, 4-azido-3-iodophenylethyl ester ([¹²⁵I]RTI 82), a cocaine analog, which had been shown in a previous study to become incorporated into different regions of the DAT primary sequence. The proximity of the photolabeled binding sites to integral membrane structures was investigated by subjecting photolabeled membrane suspensions to limited proteolysis with trypsin and separately analyzing the resulting membranes and supernatants for the presence of photolabeled DAT fragments. Trypsin treatment of [¹²⁵I] DEEP-labeled membranes generated labeled 45- and 14-kDa DAT fragments that immunoprecipitated with an epitope-specific antiserum generated against amino acids 42-59 near the first putative transmembrane domain, whereas [¹²⁵I]RTI 82 was found in 32- and 16-kDa tryptic fragments that precipitated with an antiserum directed against a sequence near transmembrane domain 4 (amino acids 225-238). All of the photolabeled fragments were recovered in the protease-treated membranes, indicating that they possess integral membrane structures that prevent their release from the membrane as soluble forms. The size of the two smallest fragments in conjunction with their retention in the membrane suggests that incorporation of the photoaffinity ligands occurs in or near membrane spanning regions and delineates the maximum possible distance between the transmembrane structures, incorporated photolabel, and antibody epitopes. Carbohydrate analysis of the fragments identified sialic acids and N-linked oligosaccharides exclusively on the 45-kDa [¹²⁵I]DEEP-labeled fragment, which, based on size, would be expected to contain four consensus glycosylation sites between putative transmembrane domains 3 and 4. Photoaffinity labeling after trypsin treatment of membranes showed that the larger but not the smaller fragments retain binding capacity, as the 45- and 32-kDa fragments were capable of becoming photolabeled. Binding of photoaffinity ligands at these fragments was displaced with the same pharmacology as that of intact DATs. These results verify numerous aspects of DAT structure and topology heretofore only predicted from theoretical considerations and extend our knowledge of DAT structure-function properties.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. L. Parnas, J. D. Gaffaney, M. F. Zou, J. R. Lever, A. H. Newman, and R. A. Vaughan Labeling of Dopamine Transporter Transmembrane Domain 1 with the Tropane Ligand N-[4-(4-Azido-3-[125I]iodophenyl)butyl]-2{beta}-carbomethoxy-3{beta}-(4-chlorophenyl)tropane Implicates Proximity of Cocaine and Substrate Active Sites Mol. Pharmacol., April 1, 2008; 73(4): 1141 - 1150. [Abstract] [Full Text] [PDF]

				R. A. Vaughan, D. S. Sakrikar, M. L. Parnas, S. Adkins, J. D. Foster, R. A. Duval, J. R. Lever, S. S. Kulkarni, and A. Hauck-Newman Localization of Cocaine Analog [125I]RTI 82 Irreversible Binding to Transmembrane Domain 6 of the Dopamine Transporter J. Biol. Chem., March 23, 2007; 282(12): 8915 - 8925. [Abstract] [Full Text] [PDF]

				L. K. Henry, J. R. Field, E. M. Adkins, M. L. Parnas, R. A. Vaughan, M.-F. Zou, A. H. Newman, and R. D. Blakely Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants J. Biol. Chem., January 27, 2006; 281(4): 2012 - 2023. [Abstract] [Full Text] [PDF]

				J. D. Gaffaney and R. A. Vaughan Uptake Inhibitors but not Substrates Induce Protease Resistance in Extracellular Loop Two of the Dopamine Transporter Mol. Pharmacol., March 1, 2004; 65(3): 692 - 701. [Abstract] [Full Text] [PDF]

				J. D. Foster, B. Pananusorn, and R. A. Vaughan Dopamine Transporters Are Phosphorylated on N-terminal Serines in Rat Striatum J. Biol. Chem., July 5, 2002; 277(28): 25178 - 25186. [Abstract] [Full Text] [PDF]

				R. A. Vaughan, J. D. Gaffaney, J. R. Lever, M. E. A. Reith, and A. K. Dutta Dual Incorporation of Photoaffinity Ligands on Dopamine Transporters Implicates Proximity of Labeled Domains Mol. Pharmacol., April 16, 2001; 59(5): 1157 - 1164. [Abstract] [Full Text]

				A. C. Thompson, A. Zapata, J. B. Justice Jr, R. A. Vaughan, L. G. Sharpe, and T. S. Shippenberg {kappa}-Opioid Receptor Activation Modifies Dopamine Uptake in the Nucleus Accumbens and Opposes the Effects of Cocaine J. Neurosci., December 15, 2000; 20(24): 9333 - 9340. [Abstract] [Full Text] [PDF]

				R. A. Vaughan, G. E. Agoston, J. R. Lever, and A. H. Newman Differential Binding of Tropane-Based Photoaffinity Ligands on the Dopamine Transporter J. Neurosci., January 15, 1999; 19(2): 630 - 636. [Abstract] [Full Text] [PDF]

				J. V. Ferrer and J. A. Javitch Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter PNAS, August 4, 1998; 95(16): 9238 - 9243. [Abstract] [Full Text] [PDF]

				E. Tirelli, B. Geter-Douglass, and J. M. Witkin gamma -Aminobutyric AcidA Agonists Differentially Augment Gnawing Induced by Indirect-Acting Dopamine Agonists in C57BL/6J Mice J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 116 - 124. [Abstract] [Full Text]